Credit Suisse’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-964,200
| Closed | -$165M | – | 3976 |
|
|
2021
Q4 | $165M | Buy |
964,200
+24,900
| +3% | +$4.08M | 0.09% | 220 |
|
|
2021
Q3 | $152M | Sell |
939,300
-27,500
| -3% | -$4.69M | 0.08% | 244 |
|
|
2021
Q2 | $159M | Sell |
966,800
-520,400
| -35% | -$86.2M | 0.08% | 243 |
|
|
2021
Q1 | $244M | Sell |
1,487,200
-225,000
| -13% | -$36.4M | 0.13% | 158 |
|
|
2020
Q4 | $269M | Buy |
1,712,200
+22,500
| +1% | +$3.32M | 0.13% | 144 |
|
|
2020
Q3 | $252M | Buy |
1,689,700
+982,200
| +139% | +$145M | 0.15% | 123 |
|
|
2020
Q2 | $99.5M | Buy |
707,500
+85,500
| +14% | +$12.5M | 0.07% | 282 |
|
|
2020
Q1 | $81.6M | Sell |
622,000
-86,500
| -12% | -$12.3M | 0.07% | 270 |
|
|
2019
Q4 | $103M | Buy |
708,500
+100,800
| +17% | +$13.7M | 0.07% | 267 |
|
|
2019
Q3 | $78.6M | Sell |
607,700
-292,800
| -33% | -$38.6M | 0.07% | 298 |
|
|
2019
Q2 | $125M | Buy |
900,500
+367,200
| +69% | +$50.8M | 0.11% | 169 |
|
|
2019
Q1 | $74.5M | Sell |
533,300
-272,000
| -34% | -$36.4M | 0.07% | 288 |
|
|
2018
Q4 | $104M | Sell |
805,300
-481,200
| -37% | -$67.1M | 0.11% | 178 |
|
|
2018
Q3 | $178M | Sell |
1,286,500
-16,600
| -1% | -$2.21M | 0.16% | 105 |
|
|
2018
Q2 | $158M | Buy |
1,303,100
+935,100
| +254% | +$117M | 0.16% | 111 |
|
|
2018
Q1 | $47.2M | Sell |
368,000
-14,700
| -4% | -$1.99M | 0.04% | 440 |
|
|
2017
Q4 | $53.5M | Buy |
382,700
+124,900
| +48% | +$17.4M | 0.05% | 402 |
|
|
2017
Q3 | $33.5M | Sell |
257,800
-134,000
| -34% | -$17.8M | 0.03% | 571 |
|
|
2017
Q2 | $51.8M | Sell |
391,800
-649,900
| -62% | -$82.9M | 0.05% | 396 |
|
|
2017
Q1 | $130M | Buy |
1,041,700
+579,700
| +125% | +$69.3M | 0.12% | 166 |
|
|
2016
Q4 | $53.2M | Buy |
462,000
+11,800
| +3% | +$1.36M | 0.05% | 381 |
|
|
2016
Q3 | $53.2M | Sell |
450,200
-42,500
| -9% | -$5.16M | 0.05% | 400 |
|
|
2016
Q2 | $59.8M | Buy |
492,700
+292,700
| +146% | +$33.3M | 0.07% | 307 |
|
|
2016
Q1 | $21.6M | Buy |
+200,000
| New | +$20.7M | 0.03% | 686 |
|
|
2015
Q2 | – | Sell |
-180,000
| Closed | -$18.1M | – | 4585 |
|
|
2015
Q1 | $18.1M | Buy |
180,000
+138,600
| +335% | +$14.1M | 0.02% | 863 |
|
|
2014
Q4 | $4.33M | Buy |
+41,400
| New | +$4.36M | ﹤0.01% | 1874 |
|
|
2014
Q2 | – | Sell |
-281,700
| Closed | -$27.7M | – | 4724 |
|
|
2014
Q1 | $27.7M | Buy |
+281,700
| New | +$26.1M | 0.03% | 671 |
|
|
2013
Q4 | – | Sell |
-54,100
| Closed | -$4.69M | – | 4645 |
|
|
2013
Q3 | $4.69M | Hold |
54,100
| – | – | ﹤0.01% | 1696 |
|
|
2013
Q2 | $4.64M | Buy |
+54,100
| New | +$4.59M | ﹤0.01% | 1634 |
|
Other funds holding JNJ
Credit Suisse's JNJ Position: Q1 2024 in Review
Credit Suisse reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2024, selling an estimated $62.4M and leaving 5,791,703 shares worth $915M. The position accounts for 0.88% of the portfolio, ranked #13.
Credit Suisse first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.26B in Q4 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.
- Credit Suisse held 5,791,703 shares of Johnson & Johnson worth $915M as of Q1 2024.
- Credit Suisse sold 391,832 Johnson & Johnson shares in Q1 2024, an estimated $62.4M.
- Johnson & Johnson made up 0.88% of Credit Suisse's portfolio in Q1 2024, its #13 holding.
- Credit Suisse first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Johnson & Johnson position peaked at $1.26B in Q4 2022.
- 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.